Project
ALXN1210-ALS-308: An Efficacy and Safety Study of Ravulizumab in ALS Patients
Aborted ยท 2020 until 2021
Neuwirth Christoph, Weber Markus, Braun Nathalie
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2020
End Date
2021
Financing
Industry
Brief description/objective
The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.